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ABSTRACT
Objectives: This literature review examined research
into the impact of a previous ‘all-clear’ or non-cancer
diagnosis following symptomatic presentation (‘false
alarm’) on symptom attribution and delays in help
seeking for subsequent possible cancer symptoms.
Design and setting: The comprehensive literature
review included original research based on quantitative,
qualitative and mixed data collection methods. We
used a combination of search strategies, including
in-depth searches of electronic databases (PubMed,
EMBASE, PsychInfo), searching key authors and
articles listed as ‘related’ in PubMed, and reference
lists. We performed a narrative synthesis of key themes
shared across studies.
Participants: The review included studies published
after 1990 and before February 2014 reporting
information on adult patients having experienced a
false alarm following symptomatic presentation. We
excluded false alarms in the context of screening.
Primary and secondary outcome measures: We
evaluated the effect of a ‘false alarm’ on symptom
attribution and help seeking for new or recurrent
possible cancer symptoms.
Results: Overall, 1442 papers were screened and
121 retrieved for full-text evaluation. Among them, 19
reported on false alarms and subsequent symptom
attribution or help seeking. They used qualitative (n=14),
quantitative (n=3) and mixed methods (n=2). Breast
(n=7), gynaecological (n=3), colorectal (n=2), testicular
(n=2), and head and neck cancers (n=2) were the most
studied. Two broad themes emerged underlying delays in
help seeking: (1) over-reassurance from the previous
‘all-clear’ diagnosis leading to subsequent symptoms
being interpreted as benign, and (2) unsupportive
healthcare experiences in which symptoms were
dismissed, leaving patients concerned about appearing
hypochondriacal or uncertain about the appropriate next
actions. The evidence suggested that the effect of a false
alarm can persist for months and even years.
Conclusions: In conclusion, over-reassurance and
undersupport of patients after a false alarm can
undermine help seeking in the case of new or recurrent
potential cancer symptoms, highlighting the need for
appropriate patient information when investigations rule
out cancer.
INTRODUCTION
Patient, doctor and system delays have all
been implicated in poorer cancer survival,
12
with particular concern in the UK that these
factors are leading to worse cancer outcomes
compared with other countries.
3–7 Public
awareness campaigns designed to promote
earlier presentation with potential cancer
symptoms, alongside improved access to diag-
nostic investigations, have been increasingly
advocated to diagnose cancer at an early
stage and improve prognosis.
89However,
only a minority of symptomatic individuals
undergoing urgent cancer investigations are
diagnosed with cancer, with more than 80%
receiving an ‘all-clear’ or non-cancer diagno-
sis (here called a ‘false alarm’).
10–12 This
Strengths and limitations of this study
▪ The review addresses an under-researched issue,
which impacts on a large number of individuals
as more than 80% of patients undergoing cancer
investigations receive a ‘non-cancer’ diagnosis
(here termed ‘false alarm’).
▪ By integrating the available evidence from quali-
tative, quantitative and mixed methods studies,
this review allowed us to identify areas that need
to be addressed in order to reduce the risk of
delayed help seeking after a previous false alarm.
▪ Over-reassurance and undersupport of patients
can be an unintended consequence of a false
alarm leading to delays in help seeking for sub-
sequent cancer symptoms. The effect on delayed
help seeking can persist for months and even
years.
▪ The included studies were mainly based on
qualitative data collection methods and were
limited by small sample size, retrospective
design and lack of control groups.
▪ Prospective studies are needed to identify the
appropriate forms of patient information to avoid
unintended consequences of false alarms on sub-
sequent symptom attribution and help seeking.
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consequences of a false alarm.
Several studies
11 13–15 have shown that investigations
for a suspected cancer can have negative effects, even
for individuals ultimately diagnosed with a benign condi-
tion. Anxiety, psychological distress
11 14 and immunoen-
docrine changes
15 can persist for weeks or months after
a benign diagnosis. In addition, an association between
false alarms and subsequent delayed diagnosis has been
reported for various cancers,
261 6 –19 with both patients
and healthcare providers contributing to delays.
6
However, evidence on the speciﬁc processes linking a
false alarm to subsequent delays in help seeking is frag-
mentary. A qualitative synthesis of patients’ help seeking
highlighted the inﬂuence of a benign diagnosis on sub-
sequent symptom attribution as well as worry about
wasting the doctor’s time as two important factors.
20
Delay in help seeking has also been attributed to the dis-
tress caused by a false alarm, and to reassurance from a
benign diagnosis.
21
Several studies have examined the psychological impact
of benign or false-positive results of cancer screen-
ing
11 22 23 and some broader inferences can be made
based on their ﬁndings. However, the psychological and
behavioural consequences of a screening-related false
alarm might not be generalisable to symptomatic
patients, as highlighted by previous studies.
24 Thus, for
our review, we focused speciﬁcally on symptomatic
patients.
According to the model of pathways to treatment,
25 the
process to diagnosis is dynamic with ‘forward and back-
ward movement’. The speed and direction of progress
through the diagnostic pathway is inﬂuenced by patient,
healthcare and disease-related factors. This dynamic
process involves both patients and healthcare providers
reconsidering and reappraising symptoms repeatedly
over time. Following a previous all-clear diagnosis, emo-
tional and cognitive factors might play a role in inﬂuen-
cing symptom attribution and help seeking, affecting
subsequent progress through the diagnostic pathway.
The aim of this study is to review the available inter-
national literature to increase our understanding of the
processes linking an all-clear diagnosis to subsequent
delays, and in particular to examine the impact on sub-
sequent symptom attribution and help seeking.
METHODS
The literature review included original research using
quantitative, qualitative and mixed data collection
methods. Identiﬁcation of relevant qualitative papers is
often difﬁcult because indexing is less well developed
than for quantitative studies,
20 so we relied on a combin-
ation of search strategies, including in-depth searches of
electronic databases (PubMed, EMBASE and PsychInfo)
using MeSH and free-text key words, searching names of
key authors and articles listed as ‘related’ in PubMed,
and searching the references in relevant publications.
The systematic search combined sets of the following
groups of keywords: (1) cancer; (2) delay, diagnostic inter-
val, diagnostic pathway; (3) benign, negative, false alarm,
all-clear, non-cancer, false positive; (4) symptoms; (5) help-
seeking, attitudes, awareness, anxiety, fear, distress, psycho-
logical, reassurance; (6) referral, repeat, investigation,
examination and test. Within each group, keywords were
combined using ‘OR’ and different groups were combined
using ‘AND’. Various combinations were used in an itera-
tive process based on the preliminary information
obtained from identiﬁed sources. This iterative search and
a ‘snowball’ approach, with one reference leading to
others,
26 proved essential because the majority of studies
were not directly addressing our research question, but
relevant information emerged once the sources were
examined in detail. Studies were included if they evaluated
the effect of health examinations that did not result in a
cancer diagnosis (here called a ‘false alarm’)o ns u b s e -
quent symptom attribution, help seeking or time to diag-
nosis, for new or recurrent possible cancer symptoms.
The focus of the review was on symptomatic patients,
because the effect of a false alarm might be different if it
occurs in the context of screening rather than symptom-
atic presentation.
24 27 We therefore excluded studies on
false alarms following screening. We also excluded
studies examining only the emotional effects of investiga-
tions for suspected cancer, as previous reviews are avail-
able on this topic.
11 13–15 Publications on childhood
cancers were excluded, as were editorials and reviews. We
included studies published after 1990 and before
February 2014 and no language restrictions were applied.
Initially, one reviewer (CR) conducted the search and
screened titles and abstracts. After having excluded irrele-
vant studies, two reviewers (CR and KLW) independently
evaluated the full text of the remaining publications,
appraised the studies and performed data extraction.
Any disagreement was resolved via a discussion.
In order to extract relevant data, we followed standard
methods:
28 the papers were read systematically by two
reviewers (CR and KLW), key concepts were recorded
and their relationship with a false alarm was explored.
Papers were read repeatedly in order to identify add-
itional concepts and identify common or contrasting
themes across studies. Using the extracted results, we
developed textual summaries and tables, which enabled
us to identify emerging themes. All three reviewers (CR,
KLW and JW) examined and discussed the ﬁndings of
individual studies and by comparing similarities and con-
trasting ﬁndings we condensed the number of themes.
The level of agreement between reviewers in identifying
key themes was high, with only minor disagreements ini-
tially regarding some subthemes that were later col-
lapsed into broader categories. Employing an iterative
process with discussions between all three reviewers, a
consensus was reached and we developed a ﬁnal narra-
tive synthesis of key themes shared across studies.
29 We
have used relevant quotes from selected qualitative and
mixed studies to illustrate our ﬁndings.
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was performed assigning a quality score to each refer-
ence according to the Mixed Methods Appraisal Tool
(MMAT).
30 The MMAT is a valid quality assessment tool
for systematic reviews including qualitative, quantitative
and mixed methods studies and evaluates each study
based on various criteria speciﬁc for the different study
designs. The highest possible score is 100% if all criteria
are met. Two reviewers (CR and KLW) assigned quality
scores independently. The level of agreement between
reviewers was high and minor disagreement regarding
only a few subscores was resolved by discussion.
Considering the limited number of studies and in line
with previous publications,
20 31 we decided not to
exclude studies based on the quality scores, but rather to
take an inclusive approach aimed at identifying research
that could give a relevant contribution.
RESULTS
We initially identiﬁed 1442 articles, of which 121 were
selected, based on the title and abstract, for full-text
evaluation (ﬁgure 1). Of these, 19 articles reported
information on symptomatic patients with a false alarm,
and considered the impact on symptom attribution,
help seeking or diagnostic delay for subsequent poten-
tial cancer symptoms.
The most frequently studied cancer was breast cancer
(n=7 studies), followed by gynaecological (n=3), colorec-
tal (n=2), testicular (n=2), head and neck (n=2), brain
cancer (n=1) and multiple cancer sites (n=2; table 1).
The majority of studies were carried out in the UK
(n=6) and the USA (n=6).
Most studies used qualitative methods (n=14), with
quantitative (n=3) and mixed methods (n=2) less fre-
quently employed. They were predominantly retro-
spective or cross-sectional, with only three having a
prospective design. Sample sizes were mainly small
and varied between 6 and 3005 participants (median
45; mean 242). The MMAT score was 100% for six
studies, 75% for three, 50–55% for eight and 25% for
two studies (table 1). Shortcomings included insufﬁ-
cient consideration/information regarding the selec-
tion and the characteristics of study participants and
insufﬁcient consideration of the possible effects of
bias, confounding and other methodological limita-
tions on the study ﬁndings (further details available
on request).
The studies provided information on the following
potential consequences of a false alarm: delayed help
seeking for cancer symptoms (n=17 studies), time to
diagnosis/delay (n=15), experience of reassurance
(n=15), symptom attribution (n=11), perceptions of
having been dismissed by the doctor (n=10), lack of
information or communication (n=7) and psychological
effects (anxiety, distress, fear; n=4). Despite differences
by cancer site, study populations and data collection
methods, two broad themes emerged across studies:
‘over-reassurance’ and ‘undersupport’.
‘Over-reassurance’ following a non-cancer diagnosis
One of the main themes emerging across studies was
patients explaining delay in help seeking as due to
reassurance from a previous benign or non-cancer diag-
nosis
21 32–45 (table 2).
Figure 1 Flow of studies.
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Authors Country
Study type and data collection
method Participants Cancer site
MMAT
quality score
(%)
Bain et al
33 UK Qualitative interviews 95 patients with cancer Colorectal 100
Beacham et al
27 USA Prospective observational (telephone
questionnaire)
37 women with benign breast biopsy following self-detected
lump, 65 following screening and control group of 76 women
without biopsy
Breast 50
Chapple et al
35 UK Qualitative interviews 45 patients with cancer Testicular 75
Evans et al
38 UK Qualitative interviews 43 patients with cancer Gynaecological 100
Facione and
Dodd
36
USA Qualitative interviews 39 patients with cancer Breast 50
Facione NC and
Facione PA
37
USA Qualitative interviews 28 women with possible breast cancer symptoms Breast 100
Fitch et al
39 Canada Qualitative interviews 18 patients with cancer Gynaecological 25
Gascoigne et al
40 UK Qualitative interviews 6 patients with cancer (and 5 relatives) Testicular 75
Granek and
Fergus
46
Canada Qualitative interviews 14 patients with cancer (and 7 partners) Breast 100
Heisey et al
21 Canada Qualitative interviews 14 patients with cancer; 10 GPs Breast 50
Janz et al
24 USA Prospective observational (telephone
questionnaire)
83 women with benign biopsy after self-discovered breast
problem (and control group of 393 women with no breast
problem)
Breast 75
Jones et al
41 Australia Cross-sectional (telephone
questionnaire)
3005 participants from the general population with potential
breast cancer symptoms
Breast 50
Salander et al
42 Sweden Qualitative interviews 28 patients with cancer and 27 spouses Brain 50
Scott et al
43 UK Qualitative interviews 57 patients with cancer Head and neck 100
Siminoff et al
44 USA Qualitative interviews (and review of
medical records)
242 patients with cancer Colorectal 100
Tarling et al
47 UK Prospective observational
(mixed-methods: questionnaire and
focus groups)
55 women with non-cancer diagnosis after urgent referral for
postmenopausal bleeding (35 completed questionnaire and 15
completed focus groups)
Gynaecological 55
Tishelman et al
34 Sweden Qualitative interviews 46 patients with cancer (and 29 relatives) Multiple sites 50
Tromp et al
32 NL Case-series (mixed methods:
questionnaire, interviews and physician
questionnaire)
306 patients with cancer Head and neck 55
Underwood et al
45 USA Qualitative interviews 46 patients with cancer Multiple sites 25
GP, general practitioner; MMAT, Mixed Methods Appraisal Tool; NL, the Netherlands.
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with breast symptoms, the single most common reason
for not seeing a doctor when experiencing a breast
lump was that they had seen a doctor about it before
(reported by 15.7% of women).
41 A study of 242 patients
with colorectal cancer (CRC) showed that a delayed
diagnosis was associated with having received an initial
non-cancer diagnosis (10.2 vs 2.4 months; p<0.001), or
having been initially told not to worry or to continue to
monitor symptoms (6.8 vs 4.4 months; p=0.006).
44 A
study of 306 patients with head and neck cancer showed
that delayed help seeking was associated with patients
interpreting symptoms as innocent partly because of
reassurance during the ﬁrst visit.
32
Qualitative studies illustrate how over-reassurance can
lead to normalisation of symptoms and subsequent
delayed help seeking: “He [physician] gave me an exam-
ination and said ‘there was nothing there’. So you go
home and live with the problem.”(No.20; patient with
CRC).
33 “He (surgeon) did a colonoscopy…He was
relieved because he didn’t ﬁnd anything- so I did nothing
for about two years and the blood wasn’t getting any
worse on the toilet paper.”(No. 48; patient with CRC).
33
Having been reassured by previous examinations, some
patients—and some physicians—attributed subsequent
symptoms to benign conditions.
21 32 33 36 38 41–43 46
Patients with breast cancer reported retrospectively: “It
was ﬁbro [something]. Yeah, benign…So…I don’t
know…I mean it was a few years later, the breast started
to feel a similar kind of way. I said, oh, it’s the same thing,
you know…And I ignored it.”(P9).
21 “When I did an
exam one day I found a different lump in each breast.
I was used to them…I was thinking, ‘Oh, here we go
again.’ And maybe for a minute you might think ‘Gee,
I hope it’s not positive’ but that went very quickly. The
more biopsies I had, the less concerned I was that they
would be positive.” (woman with four prior benign inci-
sional biopsies).
36 Some studies have even shown a
decrease in breast self-examination after a benign breast
biopsy performed for a self-detected lump.
24 27
Similarly, patients with ovarian cancer
38 and brain
tumour
42 reported delays in help seeking and specialist
referral because symptoms were attributed to a previous
benign condition or other reasonable explanations after
an initial non-cancer diagnosis and negative tests.
Likewise, for testicular cancer, a diagnosis such as a cyst
or urinary infection led to subsequent interpretation of
symptoms by patients and physicians in line with the pre-
vious benign diagnosis, with delays in help seeking and
diagnosis of up to 12 months.
40
It is possible that symptom characteristics might mod-
erate the effect of a false alarm.
32–34 38 39 42–44 For
example, among women with breast symptoms, a previ-
ous visit with a non-cancer diagnosis was a relatively fre-
quent explanation for delayed help seeking in the case
of a breast lump (reported by 15.7% of women), while it
was less frequently mentioned as a reason for delay in
the case of other symptoms, such as swelling in the
armpit, pain or change in breast shape or size.
41
‘Undersupport’ following a non-cancer diagnosis
The second broad theme was the patient’s perception of
previously not having been taken seriously, or symptoms
having been dismissed as unimportant, as well as a sense
of humiliation or concern about appearing hypochon-
driacal
21 34 36–40 42 44–46 (table 2). Women with breast
symptoms who had delayed seeking help for a year
reported that the delay was inﬂuenced by concerns
about appearing hypochondriacal or foolish, following
an experience of being dismissed or treated with disres-
pect: “I’ve had my symptoms dismissed as frivolous
twice.”
37 “Well, because I’d had identical symptoms over
20 years before, years before, and it had been mastitis.
And at that time I had worried about cancer and was
basically kind of laughed at and…and I felt foolish
about how I’d been so worried…I was very humiliated,
I was very embarrassed.” (Donna, 63, breast cancer).
46
“…So having been dismissed the ﬁrst time, I said, I’m
overreacting, just leave it alone. So that’s why I’m saying
that my ﬁrst experience kind of inﬂuenced me even
getting the follow-up the ﬁrst time I noticed any slight
change.” (P9).
21 Patients with testicular cancer also
described long delays before seeking help again for per-
sistent symptoms: “Saw the general (senior?) registrar
Table 2 Factors influencing delayed help seeking in relation to a previous all-clear diagnosis, based on the available
evidence
Main themes References
Reassurance Bain et al;
33 Chapple et al;
35 Evans et al;
38 Facione and Dodd;
36 Facione NC and Facione
PA;
37 Fitch et al;
39 Gascoigne et al;
40 Heisey et al;
21 Jones et al;
41 Salander et al;
42 Scott
et al;
43 Siminoff et al;
44 Tishelman et al;
34 Tromp et al;
32 Underwood et al
45
Symptom attribution Bain et al;
33 Beacham et al;
27 Evans et al;
38 Facione and Dodd;
36 Granek and Fergus;
46
Heisey et al;
21 Janz et al;
24 Jones et al;
41 Salander et al;
42 Scott et al;
43 Tromp et al
32
Perception of having been
dismissed
Evans et al;
38 Facione NC and Facione PA;
37 Fitch;
39 Gascoigne et al;
40 Granek and Fergus;
46
Heisey et al;
21 Salander et al;
42 Siminoff et al;
44 Tishelman et al;
34 Underwood et al
45
Lack of information/
communication
Evans et al;
38 Facione NC and Facione PA;
37 Fitch et al;
39 Siminoff et al;
44 Tarling et al;
47
Tromp et al;
32 Underwood et al
45
Anxiety, distress, fear Beacham et al;
27 Chapple et al;
35 Tarling et al;
47 Tromp et al
32
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with me and gave me one hell of a telling off for not lis-
tening to his registrar, and politely told me to bugger off
and not to waste his time again.”
40 Similarly, patients
with gastrointestinal cancer reported: “They had a very
negative attitude; I wasn’t really believed. They said it
was psychosomatic. I was reluctant to try and get help
after that.”
34
A number of studies reported that previous visits with
a non-cancer diagnosis left the patients frustrated, with a
sense that doctors could not help them and uncertainty
about what to do next; these factors contributed to sub-
sequent delays.
32 37–39 44 45 47 Of 155 patients with head
and neck cancer having initially received an all-clear,
50% waited more than 3 weeks before returning to the
doctor, and 10% more than 4 months; some explained
their delay with the fact that the doctor could not help
the ﬁrst time.
32 Likewise, lack of explanation about the
possible causes and meaning of symptoms, and lack of
advice on further actions after investigations for postme-
nopausal bleeding can delay subsequent help seeking.
47
Women reported a sense of frustration and not knowing
what to do in case of recurrent symptoms: “It’s the not
knowing. It’s more frustrating. Why is it still happening?
Mine has not changed that much. After going through
all that. It puts you off going again, because they don’t
know and they don’t tell you anything else.” (P2).
47
Similar explanations for delayed help seeking were
reported by patients with breast cancer:
37 45 “I’ve had no
relief from seeing a physician.”
37 Also patients with
ovarian cancer explained delays as due to frustration
and not having previously discussed with the doctor any
alternative diagnostic hypothesis or planned any
follow-up or further actions.
38 Among patients with
CRC, lack of communication of the next steps during
the initial visit was associated with longer diagnostic
delay (8.2 vs 3.4 months; p<0.001).
44
The other explanation for delay was anxiety or distress
following the previous non-cancer diagnosis, reported by
some women with recurrent postmenopausal bleeding
after a false alarm,
47 and by some patients with head
and neck cancer.
32 Among patients with testicular
cancer, some reported fear of painful investigations fol-
lowing previous health examinations: “And then when I
did go and see this GP, there was a locum, and he gave
me an inspection, and I found it quite uncomfortable,
the way he went about the inspection. And so I further
delayed. You know, he had referred me to somebody
else. And I delayed that…” “…it was excruciatingly
painful, you know, I didn’t like that, you know, and I
suppose anyone does like that sort of thing. Anyway, it
was my own fault that I delayed the thing.”(T45).
35
DISCUSSION
An ‘all-clear’ or non-cancer diagnosis can be associated
with subsequent delays in help seeking in the case of
new or recurrent possible cancer symptoms. Our review
of a largely qualitative literature has shown that across
different cancer sites and study populations, some
common themes emerged to help explain the relation-
ship between a false alarm and subsequent delays. The
two main themes were ‘over-reassurance’, resulting in
subsequent attribution of symptoms to the initial benign
diagnosis or normalising of symptoms, and ‘undersup-
port’, resulting in symptomatic patients being unwilling
to seek medical attention again. Many of the studies
report on prolonged delays, suggesting that the effects
of a false alarm can be long-lasting, and may generalise
beyond recurrence of the original symptom to new
symptoms appearing some time later. In the case of
breast symptoms, a benign diagnosis appeared to give
some women a false sense of security persisting for many
years.
This sense of security is at odds with the need to
remain vigilant, particularly in the light of recent evi-
dence showing that women with a histologically proven
benign breast biopsy can have a 2–3-fold increased risk
of being subsequently diagnosed with breast cancer.
48 49
Around 2% of women with a benign breast disease are
diagnosed with breast cancer during the following 7
years,
49 with the lesion being considered a marker for
increased risk, rather than a premalignant lesion in
itself. In a single institution study in the USA, 13% of
breast cancer diagnoses involved women presenting with
a palpable mass who had a negative mammogram within
the last year, and 21% had had a mammogram 1 year
or more before.
50 Also for CRC, there is evidence
supporting the need to remain vigilant even after nega-
tive investigations: up to 8% of cases are diagnosed
within 3–5 years of a negative colonoscopy, possibly
because of missed cancers or cancers arising from
missed or incompletely removed polyps.
51 In a single
institution study in the UK, the diagnostic yield of a
second urgent referral, although lower than the ﬁrst
referral (5% vs 10%), is not insigniﬁcant.
52
Our review has shown that undersupporting patients
receiving an all-clear diagnosis can negatively impact
future symptom interpretation and help seeking. The
perception that symptoms were previously dismissed as
unimportant was a relevant theme explaining subse-
quent delays, most often because of not wanting to
appear hypochondriacal. Patients’ concerns about
wasting the doctor’s time, which previous studies
reported as a common barrier for help seeking in the
UK,
20 53 54 was mentioned by some patients, but
appeared to play a less relevant role.
Fear of cancer or of the consequences of treatment
has been previously shown to be a barrier for help
seeking,
20 55 Our review suggested that fear of examina-
tions or high anxiety levels after a false alarm contribu-
ted to delays only in a minority of cases. Other factors
seemed more relevant, such as a sense of frustration,
uncertainty about what to do next and not having dis-
cussed any alternative diagnostic hypothesis or follow-up
at the time of the initial consultation.
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in the case of a non-cancer diagnosis has also been high-
lighted in a study on ‘straight to test’ endoscopy services
for suspected CRC:
56 more than 30% of patients would
prefer to see a specialist even after normal or benign
test results. A clinical encounter providing information
before and after diagnostic investigations may be valu-
able to ensure that bodily sensations are not dismissed
following negative examinations, and to discuss next
steps in the case of recurrent or new symptoms.
Our review and previous studies
42 57 have shown that
over-reassurance from normal test results or a benign
diagnosis can inﬂuence patients and healthcare provi-
ders, possibly affecting time to diagnosis. Planned
follow-up soon after the initial diagnosis can help miti-
gate the risks associated with overconﬁdence in the ﬁrst
diagnosis; it allows the clinician to apply more conscious
problem solving and for the possibility of alternative
diagnostic hypothesis to emerge, with symptom changes
guiding this process.
58 Primary care physicians can also
be undersupported in terms of not having sufﬁcient
access to diagnostic investigations.
85 9For example, 1 in
10 general practitioners in the UK had tests for ovarian
cancer refused.
60 Further studies based on healthcare
providers’ experiences are needed.
In the UK, urgent cancer examinations have risen
over time, but this is inevitably followed by a decrease in
the diagnostic yield.
52 61 More patients will experience a
false alarm as a consequence of initiatives promoting
earlier symptomatic presentation and improved access to
diagnostic investigations.
89Despite being unavoidable if
early diagnosis and survival are to be improved, espe-
cially for cancers presenting with non-speciﬁc symptoms
and in the absence of accurate markers for discriminat-
ing between high-risk and low-risk individuals, effort is
required to minimise unintended consequences.
Signiﬁcant event audits in primary care have highlighted
the need to ﬁnd a balance between avoiding unneces-
sary anxiety in symptomatic patients and the potential
risks of over-reassuring patients with an all-clear diagno-
sis.
57 Recommendations similar to those developed for
children with acute diseases have been suggested for
safety netting and preventing delays in cancer diagno-
sis.
57 62 These include communicating to patients that
there is uncertainty and that more visits might be neces-
sary for reaching a diagnosis, explaining exactly what
symptoms merit special attention, giving advice on how
to seek help if necessary, and explaining the expected
development of the illness over time.
Providing balanced information and involving patients
in monitoring their symptoms and bodily sensations are
also relevant in other contexts, such as cancer screen-
ing,
63 fast-track referral systems
64 and early detection of
recurrent cancers.
65 Electronic tools have been devel-
oped supporting people with cancer to prospectively
collect patient-reported data and for helping clinicians
to monitor trends of symptom severity.
66 Similar instru-
ments could also be used to help monitor the evolution
of symptoms in individuals with persistent or recurrent
symptoms after a false alarm with potential beneﬁcial
effects in terms of providing support and limiting
over-reassurance.
Even though the relevance of patient self-monitoring
and awareness of bodily changes is recognised in cancer
awareness campaigns (http://www.cheekycheckup.com.
au; http://www.cancerresearchuk.org) and during clin-
ical encounters, there is a lack of speciﬁc advice and
tools for patients with false alarms.
Our ﬁndings on symptomatic patients with a false
alarm are in line with some screening-related studies:
women with previous negative screening mammograms
and later diagnosed with interval breast cancer
explained delayed help seeking in part due to previous
over-reassurance and undersupport.
67 Moreover, recent
systematic reviews on the impact of false-positive screen-
ing mammograms in the UK
23 have shown long-lasting
distress for up to 3 years and a lower likelihood to reat-
tend subsequent screening assessments. There is some
weak indication that these negative effects could be over-
come by improving communication and providing tai-
lored information.
68 However, other reviews on
false-positive screening results referring to European,
Canadian and US populations showed conﬂicting evi-
dence
22 69 and more research is needed to understand
the effects of false alarms following screening as well as
following symptomatic presentation.
It should be noted that even though studies referring
to screened and to symptomatic individuals can comple-
ment each other in the attempt to increase our under-
standing of the psychological and behavioural
consequences of a false alarm, the results are not dir-
ectly transferable to different contexts. This can be
exempliﬁed by studies showing that breast self-
examination was more likely to decrease among women
with a benign diagnosis following a self-identiﬁed lump,
while it more likely increased if the breast problem was
discovered by the healthcare system.
24
There are some limitations to our review. The majority
of studies did not have the speciﬁc objective of evaluat-
ing false alarms, and relevant information emerged only
after in-depth examination of full-text publications.
Thus, we cannot exclude the possibility that some
studies were not identiﬁed in our review. The included
studies were limited by small sample size, retrospective
design and lack of control groups. As the majority of
studies were retrospective or cross-sectional and based
on reports by patients with cancer, recall bias might have
inﬂuenced the ﬁndings. When patients are asked to
recall experiences and reasons for delays after having
been diagnosed with cancer, their answers might mask a
sense of guilt if they neglected symptoms or delayed
help seeking.
67 More prospective studies are needed,
also including information provided by healthcare
professionals.
The majority of studies were conducted in
English-speaking countries, mainly the UK and the USA,
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policies and initiatives addressing earlier cancer diagno-
sis having taken place in these countries. Publication
bias might also inﬂuence the number of studies from
different countries. More international comparisons,
including central and southern European countries
could provide a different perspective on common issues.
An ‘all-clear’ diagnosis in terms of cancer can result
from a variety of different clinical scenarios, including a
true benign diagnosis, a false-negative result or the
healthcare provider attributing symptoms to alternative
explanations. Our study was not able to stratify by these
factors, but we did not identify any speciﬁc differences
regarding the effect on reassurance, symptom interpret-
ation and help seeking, of either type of, or time since,
the false alarm. Larger prospective studies are needed to
explore these issues.
In conclusion, we found that a false alarm can inﬂu-
ence subsequent symptom attribution and help seeking,
principally through patients being either ‘over-reassured’
or ‘undersupported’ in relation to future symptoms.
Providing patients with appropriate balanced informa-
tion when investigations rule out cancer may help to
prevent subsequent delays. Prospective studies are
needed to identify forms of patient information that
limit unintended consequences of false alarms.
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